Form 8-K - Current report:
SEC Accession No. 0000930413-20-002568
Filing Date
2020-11-25
Accepted
2020-11-25 17:00:29
Documents
15
Period of Report
2020-11-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 c100720_8k-ixbrl.htm   iXBRL 8-K 19031
2 c100720_ex99-1.htm EX-99.1 11337
3 GRAPHIC x1_c100720x4x1.jpg GRAPHIC 9558
  Complete submission text file 0000930413-20-002568.txt   185866

Data Files

Seq Description Document Type Size
4 enz-20201125.xsd EX-101.SCH 3416
5 enz-20201125_def.xml EX-101.DEF 10712
6 enz-20201125_lab.xml EX-101.LAB 21618
7 enz-20201125_pre.xml EX-101.PRE 11072
8 EXTRACTED XBRL INSTANCE DOCUMENT c100720_8k-ixbrl_htm.xml XML 2447
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 201351537
SIC: 8071 Services-Medical Laboratories